{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T12:10:31Z","timestamp":1775736631758,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T00:00:00Z","timestamp":1695686400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T00:00:00Z","timestamp":1695686400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1007\/s10620-023-08117-7","type":"journal-article","created":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T20:31:36Z","timestamp":1695760296000},"page":"4166-4174","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Intestinal Barrier and Gut Microbiota in Patients with Overlapping Irritable Bowel Syndrome and Functional Dyspepsia"],"prefix":"10.1007","volume":"68","author":[{"given":"Aleksandra","family":"Kovaleva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Poluektova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7513-1636","authenticated-orcid":false,"given":"Roman","family":"Maslennikov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Karchevskaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oleg","family":"Shifrin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrey","family":"Kiryukhin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandr","family":"Tertychnyy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonid","family":"Kovalev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Kovaleva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Lobanova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Kudryavtseva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Krasnov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladimir","family":"Ivashkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,26]]},"reference":[{"key":"8117_CR1","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1053\/j.gastro.2016.02.031","volume":"150","author":"BE Lacy","year":"2016","unstructured":"Lacy BE, Mearin F, Chang L, Chey WD et al. Bowel disorders. Gastroenterology. 2016;150:1393\u20131407. https:\/\/doi.org\/10.1053\/j.gastro.2016.02.031.","journal-title":"Gastroenterology."},{"key":"8117_CR2","doi-asserted-by":"publisher","first-page":"74","DOI":"10.22416\/1382-4376-2021-31-5-74-95","volume":"31","author":"VT Ivashkin","year":"2021","unstructured":"Ivashkin VT, Maev IV, Shelygin YuA et al. Diagnosis and treatment of irritable bowel syndrome: clinical recommendations of the Russian gastroenterological association and association of coloproctologists of Russia. Russ J Gastroenterol Hepatol Coloproctol. 2021;31:74\u201395. https:\/\/doi.org\/10.22416\/1382-4376-2021-31-5-74-95.","journal-title":"Russ J Gastroenterol Hepatol Coloproctol."},{"key":"8117_CR3","doi-asserted-by":"publisher","first-page":"17081","DOI":"10.1038\/nrdp.2017.81","volume":"3","author":"P Enck","year":"2017","unstructured":"Enck P, Azpiroz F, Boeckxstaens G et al. Functional dyspepsia. Nat Rev Dis Primers. 2017;3:17081. https:\/\/doi.org\/10.1038\/nrdp.2017.81.","journal-title":"Nat Rev Dis Primers."},{"key":"8117_CR4","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1097\/MCG.0b013e31826ae849","volume":"46","author":"F Scaldaferri","year":"2012","unstructured":"Scaldaferri F, Pizzoferrato M, Gerardi V, Lopetuso L, Gasbarrini A. The gut barrier: new acquisitions and therapeutic approaches. J Clin Gastroenterol. 2012;46:S12\u2013S17. https:\/\/doi.org\/10.1097\/MCG.0b013e31826ae849.","journal-title":"J Clin Gastroenterol."},{"key":"8117_CR5","doi-asserted-by":"publisher","first-page":"C1213","DOI":"10.1152\/ajpcell.00558.2003","volume":"286","author":"EE Schneeberger","year":"2004","unstructured":"Schneeberger EE, Lynch RD. The tight junction: a multifunctional complex. Am J Physiol Cell Physiol. 2004;286:C1213\u2013C1228. https:\/\/doi.org\/10.1152\/ajpcell.00558.2003.","journal-title":"Am J Physiol Cell Physiol."},{"key":"8117_CR6","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1159\/000447252","volume":"1","author":"H Fukui","year":"2016","unstructured":"Fukui H. Increased intestinal permeability and decreased barrier function: does it really influence the risk of inflammation? Inflamm Intest Dis. 2016;1:135\u2013145. https:\/\/doi.org\/10.1159\/000447252.","journal-title":"Inflamm Intest Dis."},{"key":"8117_CR7","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1002\/ibd.21403","volume":"17","author":"SY Salim","year":"2011","unstructured":"Salim SY, S\u00f6derholm JD. Importance of disrupted intestinal barrier in inflammatory bowel diseases. Inflamm Bowel Dis. 2011;17:362\u2013381. https:\/\/doi.org\/10.1002\/ibd.21403.","journal-title":"Inflamm Bowel Dis."},{"key":"8117_CR8","doi-asserted-by":"publisher","first-page":"164","DOI":"10.15252\/embr.201439263","volume":"16","author":"HE Jakobsson","year":"2015","unstructured":"Jakobsson HE, Rodr\u00edguez-Pi\u00f1eiro AM, Sch\u00fctte A et al. The composition of the gut microbiota shapes the colon mucus barrier. EMBO Rep. 2015;16:164\u2013177. https:\/\/doi.org\/10.15252\/embr.201439263.","journal-title":"EMBO Rep."},{"key":"8117_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jaci.2009.05.038","volume":"124","author":"KR Groschwitz","year":"2009","unstructured":"Groschwitz KR, Hogan SP. Intestinal barrier function: molecular regulation and disease pathogenesis. J Allergy Clin Immunol. 2009;124:3\u201320. https:\/\/doi.org\/10.1016\/j.jaci.2009.05.038.","journal-title":"J Allergy Clin Immunol."},{"key":"8117_CR10","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.15829\/1728-8800-2021-2758","volume":"20","author":"VI Simanenkov","year":"2021","unstructured":"Simanenkov VI, Maev IV, Tkacheva ON et al. Increased epithelial permeability syndrome in clinical practice multidisciplinary national consensus. Cardiovasc Ther Prev. 2021;20:2758. https:\/\/doi.org\/10.15829\/1728-8800-2021-2758.","journal-title":"Cardiovasc Ther Prev."},{"key":"8117_CR11","doi-asserted-by":"publisher","first-page":"52","DOI":"10.22416\/1382-4376-2020-30-4-52-59","volume":"30","author":"AL Kovaleva","year":"2020","unstructured":"Kovaleva AL, Poluektova EA, Shifrin OS. Intestinal barrier, intestinal permeability, nonspecific inflammation and their role in forming functional diseases of gastrointestinal tract. Russ J Gastroenterol Hepatol Coloproctol. 2020;30:52\u201359. https:\/\/doi.org\/10.22416\/1382-4376-2020-30-4-52-59.","journal-title":"Russ J Gastroenterol Hepatol Coloproctol."},{"key":"8117_CR12","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.3390\/cells9081909","volume":"9","author":"I Schoultz","year":"2020","unstructured":"Schoultz I, Keita \u00c5V. The Intestinal barrier and current techniques for the assessment of gut permeability. Cells. 2020;9:1909. https:\/\/doi.org\/10.3390\/cells9081909.","journal-title":"Cells."},{"key":"8117_CR13","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.3748\/wjg.v22.i7.2242","volume":"22","author":"E Sinagra","year":"2016","unstructured":"Sinagra E, Pompei G, Tomasello G et al. Inflammation in irritable bowel syndrome: myth or new treatment target? World J Gastroenterol. 2016;22:2242\u20132255. https:\/\/doi.org\/10.3748\/wjg.v22.i7.2242.","journal-title":"World J Gastroenterol."},{"key":"8117_CR14","doi-asserted-by":"publisher","first-page":"100655","DOI":"10.1016\/j.bbrep.2019.100655","volume":"19","author":"AA Wibowo","year":"2019","unstructured":"Wibowo AA, Pardjianto B, Sumitro SB, Kania N, Handono K. Decreased expression of MUC2 due to a decrease in the expression of lectins and apoptotic defects in colitis patients. Biochem Biophys Rep. 2019;19:100655. https:\/\/doi.org\/10.1016\/j.bbrep.2019.100655.","journal-title":"Biochem Biophys Rep."},{"key":"8117_CR15","doi-asserted-by":"publisher","first-page":"e13304","DOI":"10.1111\/nmo.13304","volume":"30","author":"L Du","year":"2018","unstructured":"Du L, Chen B, Kim JJ, Chen X, Dai N. Micro-inflammation in functional dyspepsia: a systematic review and meta-analysis. Neurogastroenterol Motil. 2018;30:e13304. https:\/\/doi.org\/10.1111\/nmo.13304.","journal-title":"Neurogastroenterol Motil."},{"key":"8117_CR16","doi-asserted-by":"publisher","first-page":"e13576","DOI":"10.1111\/nmo.13576","volume":"31","author":"M Taki","year":"2019","unstructured":"Taki M, Oshima T, Li M et al. Duodenal low-grade inflammation and expression of tight junction proteins in functional dyspepsia. Neurogastroenterol Motil. 2019;31:e13576. https:\/\/doi.org\/10.1111\/nmo.13576.","journal-title":"Neurogastroenterol Motil."},{"key":"8117_CR17","doi-asserted-by":"publisher","first-page":"248","DOI":"10.5056\/jnm19208","volume":"26","author":"JY Lee","year":"2020","unstructured":"Lee JY, Kim N, Choi YJ et al. Expression of tight junction proteins according to functional dyspepsia subtype and sex. J Neurogastroenterol Motil. 2020;26:248\u2013258. https:\/\/doi.org\/10.5056\/jnm19208.","journal-title":"J Neurogastroenterol Motil."},{"key":"8117_CR18","doi-asserted-by":"publisher","first-page":"50","DOI":"10.22416\/1382-4376-2017-27-1-50-61","volume":"27","author":"VT Ivashkin","year":"2017","unstructured":"Ivashkin VT, Mayev IV, Sheptulin AA et al. Diagnosis and treatment of the functional dyspepsia: clinical guidelines of the Russian Gastroenterological Association. Russ J Gastroenterol Hepatol Coloproctol\\. 2017;27:50\u201361. https:\/\/doi.org\/10.22416\/1382-4376-2017-27-1-50-61.","journal-title":"Russ J Gastroenterol Hepatol Coloproctol\\."},{"key":"8117_CR19","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1159\/000335692","volume":"30","author":"DJ Humes","year":"2012","unstructured":"Humes DJ. Changing epidemiology: does it increase our understanding? Dig Dis. 2012;30:6\u201311. https:\/\/doi.org\/10.1159\/000335692.","journal-title":"Dig Dis."},{"key":"8117_CR20","doi-asserted-by":"publisher","first-page":"24","DOI":"10.22416\/1382-4376-2016-26-3-24-33","volume":"26","author":"VT Ivashkin","year":"2016","unstructured":"Ivashkin VT, Sheptulin AA, Poluektova EA et al. Opportunities of 7x7 Scale (7 symptoms per 7\u00a0Days) to evaluate dynamics in symptoms of functional dyspepsia and irritable bowel syndrome. Russ J Gastroenterol Hepatol Coloproctol. 2016;26:24\u201333. https:\/\/doi.org\/10.22416\/1382-4376-2016-26-3-24-33.","journal-title":"Russ J Gastroenterol Hepatol Coloproctol."},{"key":"8117_CR21","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1023\/a:1008841022998","volume":"7","author":"DA Revicki","year":"1998","unstructured":"Revicki DA, Wood M, Wiklund I, Crawley J. Reliability and validity of the Gastrointestinal Symptom Rating Scale in patients with gastroesophageal reflux disease. Qual Life Res. 1998;7:75\u201383. https:\/\/doi.org\/10.1023\/a:1008841022998.","journal-title":"Qual Life Res."},{"key":"8117_CR22","doi-asserted-by":"publisher","first-page":"345","DOI":"10.5056\/jnm18060","volume":"24","author":"HK Jung","year":"2018","unstructured":"Jung HK, Talley NJ. Role of the duodenum in the pathogenesis of functional dyspepsia: a paradigm shift. J Neurogastroenterol Motil. 2018;24:345\u2013354. https:\/\/doi.org\/10.5056\/jnm18060.","journal-title":"J Neurogastroenterol Motil."},{"key":"8117_CR23","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1097\/MOG.0000000000000882","volume":"38","author":"BE Lacy","year":"2022","unstructured":"Lacy BE, Cangemi DJ. Updates in functional dyspepsia and bloating. Curr Opin Gastroenterol. 2022;38:613\u2013619. https:\/\/doi.org\/10.1097\/MOG.0000000000000882.","journal-title":"Curr Opin Gastroenterol."},{"key":"8117_CR24","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1111\/apt.12194","volume":"37","author":"MP Adriaanse","year":"2013","unstructured":"Adriaanse MP, Tack GJ, Passos VL et al. Serum I-FABP as marker for enterocyte damage in coeliac disease and its relation to villous atrophy and circulating autoantibodies. Aliment Pharmacol Ther. 2013;37:482\u2013490. https:\/\/doi.org\/10.1111\/apt.12194.","journal-title":"Aliment Pharmacol Ther."},{"key":"8117_CR25","doi-asserted-by":"publisher","first-page":"8671","DOI":"10.1038\/s41598-017-07242-4","volume":"7","author":"MPM Adriaanse","year":"2017","unstructured":"Adriaanse MPM, Mubarak A, Riedl RG et al. Progress towards non-invasive diagnosis and follow-up of celiac disease in children; a prospective multicentre study to the usefulness of plasma I-FABP. Sci Rep. 2017;7:8671. https:\/\/doi.org\/10.1038\/s41598-017-07242-4.","journal-title":"Sci Rep."},{"key":"8117_CR26","first-page":"326","volume":"54","author":"H Shi","year":"2015","unstructured":"Shi H, Wan J, Liu W, Su B. An analysis for the clinical difference between post infectious irritable bowel syndrome and non post infectious irritable bowel syndrome. Zhonghua Nei Ke Za Zhi. 2015;54:326\u2013329.","journal-title":"Zhonghua Nei Ke Za Zhi."},{"key":"8117_CR27","doi-asserted-by":"publisher","first-page":"7625","DOI":"10.4049\/jimmunol.0804192","volume":"182","author":"B Li","year":"2009","unstructured":"Li B, Reynolds JM, Stout RD, Bernlohr DA, Suttles J. Regulation of Th17 differentiation by epidermal fatty acid-binding protein. J Immunol. 2009;182:7625\u20137633. https:\/\/doi.org\/10.4049\/jimmunol.0804192.","journal-title":"J Immunol."},{"key":"8117_CR28","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.3389\/fimmu.2020.02054","volume":"11","author":"JA Grondin","year":"2020","unstructured":"Grondin JA, Kwon YH, Far PM, Haq S, Khan WI. Mucins in intestinal mucosal defense and inflammation: learning from clinical and experimental studies. Front Immunol. 2020;11:2054. https:\/\/doi.org\/10.3389\/fimmu.2020.02054.","journal-title":"Front Immunol."},{"key":"8117_CR29","doi-asserted-by":"publisher","first-page":"98","DOI":"10.26442\/00403660.2020.04.000568","volume":"92","author":"VT Ivashkin","year":"2020","unstructured":"Ivashkin VT, Trukhmanov AS, Gonik MI. Using rebamipide in treating gastroesophageal reflux disease. Therapeutic Archive. 2020;92:98\u2013104. https:\/\/doi.org\/10.26442\/00403660.2020.04.000568.","journal-title":"Therapeutic Archive."},{"key":"8117_CR30","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1007\/s10620-005-2800-9","volume":"50","author":"T Arakawa","year":"2005","unstructured":"Arakawa T, Higuchi K, Fujiwara Y et al. 15th anniversary of rebamipide: looking ahead to the new mechanisms and new applications. Dig Dis Sci. 2005;50:S3\u2013S11. https:\/\/doi.org\/10.1007\/s10620-005-2800-9.","journal-title":"Dig Dis Sci."},{"key":"8117_CR31","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1007\/BF01308601","volume":"38","author":"A Kleine","year":"1993","unstructured":"Kleine A, Kluge S, Peskar BM. Stimulation of prostaglandin biosynthesis mediates gastroprotective effect of rebamipide in rats. Dig Dis Sci. 1993;38:1441\u20131449. https:\/\/doi.org\/10.1007\/BF01308601.","journal-title":"Dig Dis Sci."},{"key":"8117_CR32","doi-asserted-by":"publisher","first-page":"46","DOI":"10.5009\/gnl17078","volume":"12","author":"TG Gweon","year":"2018","unstructured":"Gweon TG, Park JH, Kim BW et al. Additive Effects of rebamipide plus proton pump inhibitors on the expression of tight junction proteins in a rat model of gastro-esophageal reflux disease. Gut Liver. 2018;12:46\u201350. https:\/\/doi.org\/10.5009\/gnl17078.","journal-title":"Gut Liver."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-023-08117-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-023-08117-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-023-08117-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T11:10:53Z","timestamp":1697109053000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-023-08117-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,26]]},"references-count":32,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["8117"],"URL":"https:\/\/doi.org\/10.1007\/s10620-023-08117-7","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,26]]},"assertion":[{"value":"18 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the Local Ethics Committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}